INFUSYSTEM HOLDINGS, INC Proceeds from (Payments for) Other Financing Activities
INFUSYSTEM HOLDINGS, INC (INFU) reported Proceeds from (Payments for) Other Financing Activities of $13.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC proceeds from (payments for) other financing activities for the quarter ending 2026-06-30 was $7.50M, a 44.36% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC proceeds from (payments for) other financing activities for the quarter ending 2026-03-31 was $6.14M, a 68.05% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC proceeds from (payments for) other financing activities for the quarter ending 2025-12-31 was $6.72M, a 41.87% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC proceeds from (payments for) other financing activities for the quarter ending 2025-09-30 was $8.79M, a 17.73% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC proceeds from (payments for) other financing activities for fiscal 2025 was $48.23M, a 5.06% decline from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC proceeds from (payments for) other financing activities for fiscal 2024 was $50.80M, a 1.46% decline from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC proceeds from (payments for) other financing activities for fiscal 2023 was $51.55M, a 22.68% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC proceeds from (payments for) other financing activities for fiscal 2022 was $42.02M, a 44.85% decline from fiscal 2021.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $13.65M 10-Q · filed 2026-08-04 | $20.37M derived: sum of 3 quarters · filed 2026-08-04 | $29.16M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $6.14M 10-Q · filed 2026-05-08 | $12.87M derived: sum of 2 quarters · filed 2026-05-08 | $21.65M derived: sum of 3 quarters · filed 2026-05-08 | $35.14M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $15.51M derived: sum of 2 quarters · filed 2026-02-27 | $29.00M derived: sum of 3 quarters · filed 2026-08-04 | $48.23M 10-K · filed 2026-02-27 |
| 2025-09-30 | $8.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $22.27M derived: sum of 2 quarters · filed 2026-08-04 | $41.50M 10-Q · filed 2025-11-04 | $53.07M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $13.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $32.72M 10-Q · filed 2026-08-04 | $44.28M derived: sum of 3 quarters · filed 2026-08-04 | $51.75M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $19.23M 10-Q · filed 2026-05-08 | $30.80M derived: sum of 2 quarters · filed 2026-05-08 | $38.26M derived: sum of 3 quarters · filed 2026-05-08 | $53.96M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $11.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $19.03M derived: sum of 2 quarters · filed 2026-02-27 | $34.73M derived: sum of 3 quarters · filed 2026-02-27 | $50.80M 10-K · filed 2026-02-27 |
| 2024-09-30 | $7.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $23.16M derived: sum of 2 quarters · filed 2025-11-04 | $39.23M 10-Q · filed 2025-11-04 | $47.99M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $15.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $31.77M 10-Q · filed 2025-08-05 | $40.53M derived: sum of 3 quarters · filed 2025-08-05 | $50.74M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $16.07M 10-Q · filed 2025-05-08 | $24.83M derived: sum of 2 quarters · filed 2025-05-08 | $35.04M derived: sum of 3 quarters · filed 2025-05-08 | $50.73M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $8.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $18.97M derived: sum of 2 quarters · filed 2025-03-11 | $34.66M derived: sum of 3 quarters · filed 2025-03-11 | $51.55M 10-K · filed 2025-03-11 |
| 2023-09-30 | $10.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $25.89M derived: sum of 2 quarters · filed 2024-11-08 | $42.79M 10-Q · filed 2024-11-08 | $52.41M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $15.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $32.59M 10-Q · filed 2024-08-09 | $42.21M derived: sum of 3 quarters · filed 2024-08-09 | $53.39M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $16.89M 10-Q · filed 2024-05-09 | $26.52M derived: sum of 2 quarters · filed 2024-05-09 | $37.70M derived: sum of 3 quarters · filed 2024-05-09 | $46.39M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $9.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $20.80M derived: sum of 2 quarters · filed 2024-04-10 | $29.49M derived: sum of 3 quarters · filed 2024-04-10 | $42.02M 10-K · filed 2024-04-10 |
| 2022-09-30 | $11.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $19.87M derived: sum of 2 quarters · filed 2023-11-09 | $32.40M 10-Q · filed 2023-11-09 | $46.94M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-06-30 | $8.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $21.22M 10-Q · filed 2023-08-09 | $35.76M derived: sum of 3 quarters · filed 2024-04-10 | $49.50M derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-03-31 | $12.53M 10-Q · filed 2023-05-09 | $27.07M derived: sum of 2 quarters · filed 2024-04-10 | $40.81M derived: sum of 3 quarters · filed 2024-04-10 | $54.72M derived: sum of 4 quarters · filed 2024-04-10 |
| 2021-12-31 | $14.54M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $28.28M derived: sum of 2 quarters · filed 2024-04-10 | $42.19M derived: sum of 3 quarters · filed 2024-04-10 | $76.19M 10-K · filed 2024-04-10 |
| 2021-09-30 | $13.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $27.65M derived: sum of 2 quarters · filed 2022-11-08 | $61.65M 10-Q · filed 2022-11-08 | $67.38M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $13.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $47.91M 10-Q · filed 2022-08-04 | $53.64M derived: sum of 3 quarters · filed 2023-03-16 | $59.24M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $34.00M 10-Q · filed 2022-05-05 | $39.73M derived: sum of 2 quarters · filed 2023-03-16 | $45.33M derived: sum of 3 quarters · filed 2023-03-16 | $61.12M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $11.33M derived: sum of 2 quarters · filed 2023-03-16 | $27.12M derived: sum of 3 quarters · filed 2023-03-16 | $37.59M 10-K · filed 2023-03-16 |
| 2020-09-30 | $5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $21.39M derived: sum of 2 quarters · filed 2021-11-15 | $31.86M 10-Q · filed 2021-11-15 | $33.84M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $15.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $26.26M 10-Q · filed 2021-08-12 | $28.23M derived: sum of 3 quarters · filed 2021-08-12 | $33.67M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $10.47M 10-Q · filed 2021-05-10 | $12.44M derived: sum of 2 quarters · filed 2021-05-10 | $17.88M derived: sum of 3 quarters · filed 2021-05-10 | |
| 2019-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $7.41M derived: sum of 2 quarters · filed 2021-03-22 | $9.44M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $5.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $7.46M 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $2.02M 10-Q · filed 2020-08-14 | |||
| 2018-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $11.16M 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $9.66M 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |